These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 36312586)
1. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer. Jiang B; Zhu H; Feng W; Wan Z; Qi X; He R; Xie L; Li Y Dis Markers; 2022; 2022():9004830. PubMed ID: 36312586 [TBL] [Abstract][Full Text] [Related]
2. A cuproptosis-related gene signature and associated regulatory axis in stomach adenocarcinoma based on bioinformatics analysis. Ding D; Wang D; Qin Y Medicine (Baltimore); 2023 Jul; 102(30):e34230. PubMed ID: 37505170 [TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma. Chen Y Front Genet; 2022; 13():912037. PubMed ID: 35937995 [No Abstract] [Full Text] [Related]
4. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid Leukemia. Li Y; Kan X Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer. Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115 [TBL] [Abstract][Full Text] [Related]
6. Identification of cuproptosis-related genes for predicting the development of prostate cancer. Wang X; Chen X; Xu C; Zhou W; Wu D Open Med (Wars); 2023; 18(1):20230717. PubMed ID: 37711156 [TBL] [Abstract][Full Text] [Related]
7. A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas. Zhu H; Wan Q; Tan J; Ouyang H; Pan X; Li M; Zhao Y Front Genet; 2022; 13():992995. PubMed ID: 36579333 [No Abstract] [Full Text] [Related]
8. Comprehensive analysis of cuproptosis genes and cuproptosis-related genes as prognosis factors in esophageal squamous cell carcinoma. Wu Z; Huang Z; Zhou X; Gao C; Peng Z; Zheng X; Zhang Y; Du Z; Wu B Genomics; 2023 Nov; 115(6):110732. PubMed ID: 37866660 [TBL] [Abstract][Full Text] [Related]
9. Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy. Yang X; Zhang X; Shen K; Wang Z; Liu G; Huang K; He Z; Li Y; Hou Z; Lv S; Zhang C; Yang H; Liu S; Ke Y Front Pharmacol; 2023; 14():1033859. PubMed ID: 37435496 [No Abstract] [Full Text] [Related]
10. A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity. Liu J; Lu Y; Dai Y; Shen Y; Zeng C; Liu X; Yu H; Deng J; Lu W Front Genet; 2022; 13():939956. PubMed ID: 36105090 [No Abstract] [Full Text] [Related]
11. Cuproptosis-Related Genes Are Associated with Cell Cycle and Serve as the Prognostic Signature for Clear Cell Renal Cell Carcinoma. Guo T; Zhang J; Yuan Z; Tang H; Wang T; Wang X; Chen S J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556123 [TBL] [Abstract][Full Text] [Related]
12. Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer. Zhou C; Li C; Zheng Y; Huang X Front Oncol; 2022; 12():934076. PubMed ID: 36387247 [TBL] [Abstract][Full Text] [Related]
13. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer. Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617 [TBL] [Abstract][Full Text] [Related]
14. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma. Bian Z; Fan R; Xie L Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236 [TBL] [Abstract][Full Text] [Related]
15. Identification of Cuproptosis-Related circRNA-miRNA-mRNA Network in Laser-Induced Choroidal Neovascularization Models and in Peripheral Blood Mononuclear Cells of Patients with Neovascular Age-Related Macular Degeneration. Zhang M; Wu J; Wang Y; Wan X; Liu H; Sun X Ophthalmic Res; 2023; 66(1):1417-1432. PubMed ID: 37989109 [TBL] [Abstract][Full Text] [Related]
16. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA. Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P Front Immunol; 2022; 13():919231. PubMed ID: 35967366 [TBL] [Abstract][Full Text] [Related]
17. A novel cuproptosis-related prognostic gene signature in adrenocortical carcinoma. Gao W; He X; Huangfu Q; Xie Y; Chen K; Sun C; Wei J; Wang B J Clin Lab Anal; 2023 Nov; 37(21-22):e24981. PubMed ID: 37997497 [TBL] [Abstract][Full Text] [Related]
18. In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma. Wang Y; Huang X; Chen S; Jiang H; Rao H; Lu L; Wen F; Pei J Curr Oncol; 2022 Sep; 29(9):6573-6593. PubMed ID: 36135086 [TBL] [Abstract][Full Text] [Related]
19. Distinct cuproptosis patterns in hepatocellular carcinoma patients correlate with unique immune microenvironment characteristics and cell-cell communication, contributing to varied overall survival outcomes. Wang Y; Mang X; Guo X; Pu J Front Immunol; 2024; 15():1379690. PubMed ID: 38868777 [TBL] [Abstract][Full Text] [Related]
20. Identification of 10 differentially expressed and cuproptosis-related genes in immune infiltration and prognosis of thyroid carcinoma. Yu W; Liu H; Zhang Y; Liu M; Li W; Wang L; Li D Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):89-94. PubMed ID: 38650151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]